U.K. Healthcare Services Stock News

Why Hochschild Mining is on investors’ radar Hochschild Mining (LSE:HOC) has drawn attention after recent price moves, with the share price showing a 2.5% gain over the past day, compared with a weaker performance over the past week and month. See our latest analysis for Hochschild Mining. That 2.5% one day share price gain comes after a 22.5% 30 day share price decline. However, the 1 year and 3 year total shareholder returns are very large, suggesting long term momentum while short term...

Rio Tinto Group (LSE:RIO) has signed an earn in agreement with LCL Resources for copper gold exploration in Papua New Guinea. The arrangement introduces staged funding and could allow Rio Tinto to increase its ownership stake in the project to 80% over time. The partnership gives Rio Tinto exposure to a mineral rich, underexplored copper gold region that is relevant to energy transition metals. For investors watching Rio Tinto at a share price of £64.81, this new exploration agreement adds...

Shell (LSE:SHEL) has approved a substantial pay rise for CEO Wael Sawan. The decision comes as UK boards show greater acceptance of higher executive compensation to compete globally for top talent. The move reflects a broader shift in UK corporate governance attitudes toward leadership incentives and pay structures. Shell, a major integrated energy company, sits at the center of the global oil, gas and liquefied natural gas supply chain while also investing in lower carbon solutions. In...

If you are wondering whether Pan African Resources is still good value after its strong run, the starting point is understanding what the current share price actually reflects. The stock closed at £1.256, with recent moves that include a 16.4% decline over 7 days and a 25.2% decline over 30 days, set against a 4.7% year to date return and a very large 1 year gain of 219.9%. These returns sit alongside multi year gains that are also very large over 3 and 5 years. This naturally raises...

Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...

Hill & Smith PLC's ( LON:HILS ) solid earnings announcement recently didn't do much to the stock price. Our analysis...

Why AstraZeneca is on investors’ radar today AstraZeneca (LSE:AZN) has attracted fresh attention after a recent pullback, with the share price down about 9% over the past month, while performance over the past three months remains slightly positive. For investors tracking large pharma, that move is being considered alongside AstraZeneca’s £215.5b market value, revenue of £58,739.0m and net income of £10,225.0m, as well as its current £138.96 share price. See our latest analysis for...

Lloyds Banking Group (LSE:LLOY) has come into focus after shares closed at £0.91. Recent returns over the past month and past 3 months are both in negative territory, prompting fresh interest in its valuation. See our latest analysis for Lloyds Banking Group. At the latest share price of £0.9078, Lloyds Banking Group’s recent momentum has softened, with a 1-month share price return of 13.21% and year to date share price return of 8.52%, while the 1-year total shareholder return of 35.07%...

BP has agreed to sell its Gelsenkirchen refinery in Germany to Klesch Group as part of a broader effort to refocus its business and reduce costs. At the same time, more than 800 union workers have been locked out of BP's Whiting, Indiana refinery during ongoing labor contract negotiations. These developments affect core refining operations in both Europe and the U.S., raising questions about operational continuity and workforce relations. For investors watching LSE:BP, these moves come with...

Wondering if HSBC Holdings is still offering value at around £11.44 a share, or if the easy gains are already behind it. The stock has pulled back recently, with a 3.1% decline over the last 7 days and an 11.8% decline over the past month, even after returns of 36.5% over 1 year and very large gains over 5 years. Recent coverage has focused on HSBC Holdings as a major global bank responding to shifting interest rate expectations, regulatory developments and capital return policies. All of...

Diageo (LSE:DGE) is reported to be considering a potential spin off of its Guinness brand following a period of challenging financial results. The company is also pursuing new brand partnerships and product launches as consumer demand shifts towards lower priced spirits. These moves suggest Diageo is reassessing how Guinness and its broader portfolio fit together after a weaker trading period. For anyone following global drinks groups, Diageo is one of the largest listed spirits and beer...

Wondering if Unilever shares at around £45.96 still offer solid value or if the easy gains are behind you? This article walks through what the current price really implies. The stock has seen a 4.9% decline over the last 7 days, a 13.7% decline over 30 days, is down 4.7% year to date, yet shows returns of 13.4% over 3 years and 26.7% over 5 years, which can leave the current risk and reward balance feeling unclear. Recent coverage has continued to focus on Unilever as a global consumer...

Some investors may be wondering if British American Tobacco at around £43.11 is still offering value after a strong run, or if most of the easy gains are already behind it. The stock has seen a 45.7% return over the last year and a 2.9% return year to date. Shorter term moves include a 4.6% decline over 7 days and a 0.8% decline over 30 days, which can shift how investors think about both upside and risk. Recent coverage has focused on British American Tobacco in the context of broader...

Wondering whether Lloyds Banking Group at around £0.92 a share still represents solid value or if much of the opportunity is already priced in? This article walks through the key numbers to help you frame that question. The stock has pulled back recently, with an approximate 2.8% decline over the last week and 12.5% over the last month, even though the 1 year return sits at 36.2% and the 3 year and 5 year figures are very large. That mix of shorter term weakness and stronger longer term...

GSK (LSE:GSK) has received FDA approval for Lynavoy (linerixibat) as the first treatment in the US for cholestatic pruritus in primary biliary cholangitis. The approval is based on Phase III data and targets a rare liver disease symptom that significantly affects quality of life. GSK has signed a licensing agreement granting Alfasigma exclusive worldwide rights to develop, manufacture, and commercialise linerixibat. Lynavoy adds a rare disease medicine to GSK's portfolio, which already...

Recent performance and why Diageo is drawing attention Diageo (LSE:DGE) has come back into focus for investors after a tough run, with the share price showing a 22% decline over the past month and a 16% decline over the past 3 months. See our latest analysis for Diageo. The recent 22% 1 month share price decline sits within a weaker backdrop, with a 12.78% year to date share price fall and a 30.61% 1 year total shareholder return decline. This suggests momentum has been fading as investors...

NatWest Group has announced the full redemption of all outstanding Notes issued under a specified trust deed. The redemption will retire these instruments under its debt financing arrangements, affecting the group’s overall debt profile. The action is framed as part of NatWest Group’s broader capital management decisions. For investors watching LSE:NWG, the move comes with the shares trading around £5.336 and following a mixed return profile. The stock shows a 23.1% gain over 1 year and...

If you are wondering whether BP's current share price reflects its true worth, the recent numbers give plenty to think about. The stock last closed at £5.832, with returns of 10.2% over 7 days, 26.7% over 30 days, 33.2% year to date, 37.7% over 1 year, 37.1% over 3 years and 154.7% over 5 years. Recent news around BP has focused on its position in the global energy market and ongoing efforts to balance traditional oil and gas operations with lower carbon initiatives. These developments give...

Barclays CEO C.S. Venkatakrishnan has addressed the bank's exposure to the collapsed UK lender Market Financial Solutions. He indicated that expected credit impairments tied to this exposure and to private credit positions are now forecast to be lower than initially feared. The CEO also reaffirmed Barclays' existing financial guidance, while stressing that broader systemic risks from private credit funds appear limited for the bank. For investors watching LSE:BARC, these comments follow a...

Shell (LSE:SHEL) is back in focus after recent share price moves, with the stock showing mixed short term performance but stronger figures over the month and past 3 months that may interest income and value focused investors. See our latest analysis for Shell. At a share price of £34.615, Shell’s 20.8% 30 day share price return and 25.44% year to date share price return sit alongside a 31.36% 1 year total shareholder return and 188.21% 5 year total shareholder return. This may suggest...

Recent performance snapshot for Rio Tinto Group (LSE:RIO) Rio Tinto Group (LSE:RIO) has seen mixed share performance recently, with a 1 day return of about a 1.4% decline and a 7 day move of roughly a 1.9% decline, alongside a larger pullback over the past month. Over the past 3 months and year to date, the stock shows positive total returns. In contrast, the 1 year and 5 year figures indicate stronger gains, which may prompt investors to reassess current pricing. See our latest analysis for...

AstraZeneca’s Saphnelo has rapidly become physicians’ preferred biologic treatment for cutaneous lupus erythematosus, overtaking GSK’s Benlysta. Clinicians are showing strong interest in Saphnelo across additional autoimmune indications, ahead of multiple pivotal trial readouts. The news highlights AstraZeneca’s growing role in immunology alongside its established oncology presence. AstraZeneca (LSE:AZN) is drawing fresh attention as Saphnelo gains traction in cutaneous lupus erythematosus,...

Why British American Tobacco is back on income investors’ radar With no single headline event driving attention, British American Tobacco (LSE:BATS) is drawing interest as investors reassess a large, established tobacco group with sizeable earnings, global reach and a mix of traditional and newer nicotine products. The shares last closed at £45.44, and the company reports annual revenue of £25.61b and net income of £7.68b, supported by operations across the United States, Europe, Latin...

Unilever share performance and business snapshot Unilever (LSE:ULVR) has attracted fresh attention after a month in which the share price showed a 10.16% decline. This has prompted investors to reassess the consumer goods group’s scale, profitability and recent return profile. The company operates a broad fast moving consumer goods portfolio across Beauty & Wellbeing, Personal Care, Home Care and Foods, with reported annual revenue of €50,503.0m and net income of €5,682.0m. Its current market...